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133 Virulence properties of Achromobacter xylosoxidans: cytotoxic
activity, interleukin production, bioﬁlm formation and invasion
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Achromobacter xylosoxidans has been associated with cystic ﬁbrosis (CF), but
its role on human pathogenicity is still not known. Recently we described the
cytotoxic activity of cultured supernatants (CS) of A. xylosoxidans to human lung
cells (H-460). Among the proteinase studied, lecithinase was the only one detected.
Now, the culture supernatants of A. xylosoxidans also showed cytotoxic activity on
NCI-H292 (human lung mucoepidermoid carcinoma) and this cytotoxic acitivity
was not afected after heat treatment (100ºC for 20 min), showing it to be thermo
stable. The protein fractions obtained by ultraﬁltration (Amiconaˆ), showed biological
activity of the extracts with molecular weigh lower than 5 kDa. This fraction has also
stimulated the IL 8 production by these lung cells of 5 folds more than that detected
on the negative controls, determined by ELISA (DuoSet, RD Systems, EUA. These
data suggests that the thermo stable cytotoxic activity (cytotoxin), is probably the
stimulating agent of the proinﬂamatory cytokine (IL) that may be related to the
pathogenicity for lung cells. A. xylosoxidans showed bioﬁlm formation ability on
plastic microplates among all the isolates, as veriﬁed by ﬂat-bottom microtiter
polystyrene plates test. Invasion and intracellular survival in NCI-H292 cells was
also observed. The detection of a cytotoxic factor inducing IL 8 production, the
bacteria bioﬁlm formation and invasion reinforces the proposal that A. xylosoxidans
may present a relevant role in the lung parenchyma destruction in cystic ﬁbrosis
patients.
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Purpose: Aspergillus fumigatus colonisation is common in cystic ﬁbrosis (CF)
but prevalence varies between studies from 12−57%. Colonised patients are not
routinely treated with antifungals. This study aimed to accurately identify patients
with A. fumigatus colonisation using Real time PCR and examine the relationship
to markers of sensitisation.
Methods: 49 adult CF patients provided a sputum sample, a blood sample for
Aspergillus serology and had fungal skin prick tests. Serological tests included
total IgE, speciﬁc IgE A. fumigatus and speciﬁc IgG A. fumigatus performed by
Phadia ImmunoCAP® assay, and A. fumigatus precipitins by counterimmunoelec-
trophoresis. A commercial Real time PCR kit, MycAssay™ Aspergillus, was used
to detect Aspergillus in CF sputum samples.
Results: 15 of the 49 sputum samples were PCR positive for Aspergillus species.
All PCR positive samples had a positive speciﬁc IgG titre (>40mg/L) but 41%
of PCR negative samples also had a positive IgG titre. PCR positive patients had
a signiﬁcantly greater mean speciﬁc IgG Aspergillus (PCR positive 93mg/L SE
6.74 versus PCR negative 47mg/L SE 4.44 p 0.001). Using a ROC curve, an IgG
level above 67mg/L gives 85% sensitivity and 90% speciﬁcity for positive PCR.
No other marker of A. fumigatus sensitisation correlated to positive PCR.
Conclusion: Real time PCR can be used to identify patients colonised or infected
with Aspergillus, including those in whom antifungal therapy is inadequate. A
speciﬁc IgG titre above 67mg/L correlates with ﬁnding Aspergillus in sputum by
PCR. Additional data are required to determine which marker(s) is most useful for
treatment decision-making.
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Background: The use of a selective medium such as erythritol-chloramphenicol
agar (ECA) has been highly recommended for the isolation of Exophiala dermati-
tidis (ED) from respiratory secretions of CF patients. However, using the Sabouraud
Gentamicin-Chloramphenicol Agar (SGCA) medium (Becton-Dickinson), we re-
cently observed ED isolation rate in CF patients similar to that mentioned in the
mycological literature.
Aim: To compare the ability of ECA and SGCA to detect ED in respiratory cultures
from CF patients.
Methods: Over a 8-weeks period, isolation rates of ED from all consecutive sputum
samples from non lung-transplanted CF patients in our clinic were assessed using
both ECA (incubated 4 weeks at 35ºC) and SGCA medium (incubated 4 weeks at
29ºC).
Results: 235 samples from 132 patients (48% >18 y) were cultured (sputum −
when possible − or deep pharyngeal aspirate after a session of physiotherapy).
PA and BCC (multivorans or vietnamiensis) were cultured from 22.5% and 2.1%
of samples respectively. ED was isolated from the same 11 specimens (4.7%), in
8 patients (6.1%) irrespective of using the ECA or the SGCA medium. With either
medium too, ED was detected in all but one case between day 4 and day 8.
Conclusion: In this comparative study, ECA did not yield higher isolation rates of
ED than the commercially available and less costly SGCA medium.
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Background: Exophiala dermatitidis (ED) is considered as an emerging colonizing
fungal agent in patients with CF.
Aim: To assess the ability of ED to chronically infect the airways of CF patients.
Methods: By analogy to current deﬁnitions of chronic infection by Ps. aeruginosa,
chronic infection by ED was deﬁned in 2 ways: (1) ED + culture in 50% of the
past 12 months with a respiratory culture (criterion 1) [1]; (2) presence of ED in
the bronchial tree for at least 6 months, based on at least three positive cultures
with at least one month intervals between them (criterion 2), with speciﬁc antibody
response (criterion 3) [2]. Precipitating antibodies against ED were investigated by
agar gel double immunodiffusion. The presence of at least 2 lines of precipitins
was considered signiﬁcant.
Results: Over a 2-years period, 9 patients (5.8%) in our CF clinic had at least
1 ED + culture (mean number of cultures/patient/2 y: 13, range:10−20; mean %
of ED + cultures: 46%). Criteria 1, 2 and (2+3) were met by 5, 6 and 5 patients
respectively. According to criterion 1 or (2+3), 6 patients could be considered as
chronically infected by ED. Two lines of precipitins against ED were observed in
only 1 out of 9 carefully matched ED− CF patients.
Conclusion: These data suggest that ED can chronically infect the airways of
CF patients.
Reference(s)
[1] Lee et al. J Cyst Fibros 2003; 2: 23.
[2] Do¨ring et al. Eur Respir J 2000; 16: 749.
